Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2020Cited by 160
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Thor Petersen, Helle Hvilsted Nielsen et al.|Neurology|2018Cited by 104
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)Morten Riemenschneider, Ulrik Dalgas, Lars G. Hvid et al.|Multiple Sclerosis Journal|2022Cited by 48
Comparative effectiveness of teriflunomide and dimethyl fumarateMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2019Cited by 45
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort studyTine Iskov Kopp, Melinda Magyari, Morten Blinkenberg et al.|Multiple Sclerosis and Related Disorders|2020Cited by 41